Challenge
An international technology company expanding into pharma manufacturing needed to confirm its CMC strategy before committing further.
Approach
NGT reviewed and validated the company's CMC drug development strategy and identified where costs could come down.
Outcome
The company validated its strategy, reduced costs, and secured late-stage investment and a commercial partnership.
Disciplines involved